Eltropag Tablet Substitute
›
Cipla Ltd
₹917.5
(₹117.97 per unit)
Glenmark Pharmaceuticals Ltd
₹1539.5
(₹197.94 per unit)
BDR Pharmaceuticals Internationals Pvt Ltd
₹2340
(₹210.6 per unit)
Zydus Cadila
₹1692
(₹217.54 per unit)
Hetero Healthcare Pvt Ltd
₹2175
(₹279.64 per unit)
Celon Laboratories Pvt Ltd
₹2304
(₹296.23 per unit)
Intas Pharmaceuticals Ltd
₹3000
(₹300.0 per unit)
Natco Pharma Ltd
₹2343.5
(₹301.31 per unit)
Bharat Serums and Vaccines Ltd
₹2343.5
(₹301.31 per unit)
Lucien Life Sciences
₹2343.5
(₹334.79 per unit)
Aureate Healthcare
₹4218.5
(₹345.92 per unit)
Msn Laboratories Pvt Ltd
₹2887.5
(₹363.0 per unit)
Medion Biotech Pvt Ltd
₹3309.95
(₹387.74 per unit)
Delarc Pharmaceuticals Pvt Ltd
₹7875
(₹562.5 per unit)
GlaxoSmithKline Pharmaceuticals Ltd
₹15656
(₹1968.19 per unit)
Patients may explore substitutes in the following scenarios:
Before you switch from Eltropag Tablet to another medicine, here are some important points to keep in mind:
Same salt, different brands:
Most substitutes contain the same active ingredient - ELTROMBOPAG-50MG, but the fillers, coating, or manufacturing quality may vary slightly.
Consult your doctor first:
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Watch out for allergies or reactions:
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
Price ≠ effectiveness:
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Check the dosage form and strength:
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Eltropag Tablet contains 'Eltrombopag,' which belongs to the class of 'thrombopoietin receptor agonists' used to treat low blood platelet count in patients with immune (idiopathic) thrombocytopenic purpura (ITP), hepatitis C virus (HCV) infections and severe aplastic anaemia (SAA) in adults. Eltropag Tablet works by increasing megakaryocytes, the large bone marrow cells responsible for the production of platelets. The increase in these bone marrow cells stimulates the production of platelets. Thus Eltropag Tablet prevents bleeding episodes by increasing the number of platelets in the blood.
The substitutes of Eltropag Tablet contain the same active salt(s) - ELTROMBOPAG-50MG. However, they may differ in price, manufacturing quality, and inactive ingredients. Speak to your doctor to find a suitable option.
Switching to a generic substitute medicine in the place of Eltropag Tablet is often possible if it has the same salt, strength, and dosage form. But always check with your doctor before making any changes to your medication.
Generics versions of Eltropag Tablet are typically more affordable because they don’t include the original brand's research, development, and marketing costs. They contain the same active ingredient and are approved for safety and effectiveness.
Most people don’t notice any difference. However, some may react to different fillers or coatings. If you notice any unusual symptoms after switching, consult your doctor.
Make sure the new medicine has the same active salt, strength, dosage form. Always confirm the change with your doctor or pharmacist.
Substitutes of Eltropag Tablet meet the same safety and efficacy standards as Eltropag Tablet, but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.
Yes. Substitutes of Eltropag Tablet may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.
Yes, it’s generally safe to switch between multiple substitutes of Eltropag Tablet if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.
Yes, many people safely use substitutes of Eltropag Tablet for long-term treatment. Just ensure it’s done under medical supervision.
If your symptoms stay under control or lab results remain stable, the substitute for Eltropag Tablet is likely working well. Regular follow-ups with your doctor are important.
Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Eltropag Tablet to its substitute. Always consult your doctor before switching.
Eltropag Tablet contains Eltrombopag that stimulates platelet's production (helps in clotting) from megakaryocytes (bone marrow cells). Thus Eltropag Tablet lowers the risk of bleeding episodes in diseases like immune (idiopathic) thrombocytopenic purpura (ITP), hepatitis C virus (HCV) infections and severe aplastic anaemia (SAA).
Do not stop using Eltropag Tablet even if you feel better. It should be strictly used as advised by your doctor to avoid the recurrence of symptoms and worsening of the disease.
Eltropag Tablet should be used with caution and only under doctor's supervision in cases of any allergic reactions, blood clots, clotting disorders (Factor V Leiden), blood disorders like blood cancer, myelodysplastic syndrome, cataracts, liver or kidney diseases.
Eltropag Tablet decreases the risk of bleeding by increasing the platelet count in your body. However, you are advised to stay away from activities that may increase your risk of bleeding like contact sports and using sharp objects like razors and nail cutters.
It is advised to take Eltropag Tablet on an empty stomach. Please take Eltropag Tablet at least two hours before or four hours after consuming antacids, mineral and vitamin supplements (iron, calcium, magnesium, aluminium, selenium and zinc), dairy products, calcium-enriched foods and fortified juices since they interfere with the absorption of Eltropag Tablet.